[1]钟伟芬*,晏红锦,杨丽君,等.低分子肝素治疗复发性流产患者凝血及血液流变学状态观察[J].中国计划生育和妇产科,2020,(5):29-32.
　ZHONG Weifen*,YAN Hongjin,YANG Lijun,et al.Observation of coagulation and hematological status in RSA patients treated with LMWH[J].Chinese Journal of Family Planning & Gynecotokology,2020,(5):29-32.
点击复制

低分子肝素治疗复发性流产患者凝血及血液流变学状态观察
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年5期
页码:
29-32
栏目:
不良妊娠诊治专栏
出版日期:
2020-05-25

文章信息/Info

Title:
Observation of coagulation and hematological status in RSA patients treated with LMWH
作者:
钟伟芬1*; 晏红锦1; 杨丽君2; 李萍2; 朱小红1 ; 杨洁萍2
1. 510800广东广州，广州市花都区人民医院妇产科；2. 510160广东广州，广州市妇女儿童医疗中心妇科
Author(s):
ZHONG Weifen1*; YAN Hongjin1; YANG Lijun2; LI Ping2; ZHU Xiaohong1; YANG Jieping2
1.Department of Obstetrics and Gynecology,Huadu District People's Hospital of Guangzhou,Guangzhou Guangdong 510800,P.R.China;2.Department of Gynecology,Guangzhou Women and Children Medical Center,Guangzhou Guangdong 510160,P.R.China
关键词:
低分子肝素; 复发性流产; 凝血; 血液流变学
Keywords:
low molecular weight heparin; recurrent spontaneous abortion;  coagulation;  blood rheology
分类号:
R 71;R 39
摘要:
目的 探讨不明原因复发性流产（recurrent spontaneous abortion,RSA）患者凝血功能和血液流变学状况及低分子肝素（low molecular weight heparin，LMWH）在 RSA 患者妊娠中的临床应用。方法选择2018年于广州市花都区人民医院及广州市妇女儿童医疗中心妇科门诊就诊的 RSA 患者30例，以 LMWH 治疗作为治疗组；30例同期正常产检孕妇为对照组。比较血浆D二聚体(Ddimer，DD)，凝血酶原时间(prothrombin time，PT),部分活化凝血酶时间（activated partial thromboplastin time，APTT）变化情况；比较两组血液流变学变化情况；同时观察治疗组 LMWH 使用过程中不良反应的发生情况。结果 孕前、孕6周及孕8周时，治疗组 DD 数值较同期对照组高；组内比较随着孕周增加而增加；孕前 PT,APTT 均较正常组低，差异均有统计学意义（P<005）； 孕6周及孕8周时，治疗组患者的 PT,APTT 数值，与对照组比较，差异无统计学意义（P>005）；孕前治疗组和对照组两组间全血比黏度、全血还原比黏度、血浆比黏度血液流变学指标比较，差异均有统计学意义(P<0．05)。孕6周及8周时，治疗组血液流变学的各项异常指标治疗后与对照组比较, 差异无统计学意义(P>0．05);治疗组使用 LMWH 的30例患者中5例出现脐周注射部位皮下小面积瘀青，发生率为1667 %（5/30）。仅1例患者出现皮下注射部位轻度疼痛不适感，发生率为333 %（1/30）。结论小剂量 LMWH能安全有效地改善RSA 患者凝血及血液流变学状态。
Abstract:
ObjectiveTo explore the coagulation and hematological status and clinical application of low molecular weight heparin(LMWH) in pregnant women with recurrent spontaneous abortion(RSA). MethodsThirty cases of RSA patients attending gynecological outpatient clinic at Huadu District People's Hospital of Guangzhou and Guangzhou Women and Children Medical Center in 2018 were selected as treatment group with LMWH treatment; 30 cases of pregnant women undergoing normal obstetric examination at the same time were selected as control group. To compare the changes in plasma Ddimer(DD), prothrombin time(PT), and activated partial thromboplastin time(APTT); to compare the blood rheology of the two groups; and to observe the occurrence of adverse reactions during LMWH use in the treatment group. ResultsThe DD values in the prepregnancy, 6 weeks and 8 weeks were higher in the treatment group than in the control group; the intragroup comparison increased with increasing gestation weeks; the prepregnancy PT and APTT were lower than the control group, and the differences were statistically significant(P<005); the PT and APTT values in the treatment group were not statistically different(P>005) when compared with the control group at 6 weeks and 8 weeks; the differences in the whole blood ratio viscosity, whole blood reduction ratio viscosity and plasma ratio blood rheology indicators prepregnancy between the treatment group and the control group were statistically significant(P<005). At 6 and 8 weeks of gestation,there was no statistical difference of the abnormal blood rheology indicators between the treatment group after the treatment and the control group;5 out of 30 patients who used LMWH in the treatment group had small subcutaneous bruising at the injection site of the umbilical cord, and the incidence was 1667 % (5/30). Mild painful discomfort at the subcutaneous injection site occurred in only 1 patient with an incidence of 333 % (1/30). ConclusionSmall doses of LMWH can safely and effectively improve coagulation and hematological status in patients with RSA.

参考文献/References:

［1］Practice Committee of American Society for Reproductive Medicine Definitions of infertility and recurrent pregnancy loss: a committee opinion ［J］ Fertility and Sterility, 2013, 99(1): 63. ［2］Stefanski A L, Specker C, Fischerbetz R, et al. Maternal thrombophilia and recurrent miscarriageis there evidence that heparin is indicated as prophylaxis against recurrence? ［J］. Geburtshilfe und Frauenheilkunde, 2018, 78(3): 274282. ［3］Ni Lei, Sun Xueqian, Zhao Dongxu, et al. Low molecular weight heparin monotherapy for recurrent abortion with anti phospholipid system: A protocol of a systematic review ［J］. Medicine, 2019, 98(8): e14619. ［4］何淑贞，蒲育栋，曹金如，等．血清和糖皮质激素诱导激酶1 rs9402571和rs72550326与复发性流产的关系 ［J］．广东医学，2016，37（12）：18341835． ［5］侯悦，张凤悦，李媛媛，等．不明原因复发性流产患者孕前主动免疫2次前后外周血淋巴细胞亚群及自身免疫性抗体变化的前瞻性研究 ［J］．中国计划生育和妇产科，2018，10（9）：2831． ［6］王曌华，张建平．血栓前状态与复发性流产及抗凝治疗 ［J］．中国实用妇科与产科杂志，2013，29（2）：102106． ［7］张振武，刘津．淋巴细胞主动免疫在复发性流产治疗中的效果及血液流变学的临床意义［J］．中国妇幼保健，2016，31（10）：21542156． ［8］康丹阳, 杨巧妮, 乔宠. 应用血栓弹力图监测不同流产次数的复发性流产患者凝血功能变化情况 ［J］. 中国计划生育和妇产科， 2017，9 (2)：2225. ［9］Karada C, Yoldemir T, Karada S D, et al. Obstetric outcomes of recurrent pregnancy loss patients diagnosed wth inherited thrombophilia ［J］. Irish Journal of Medical Science, 2017, 186(3): 707713. ［10］Skeith L, Carrier M, Kaaja R, et al. A metaanalysis of lowmolecularweight heparin to prevent pregnancy loss in women with inherited thrombophilia ［J］. Blood, 2016,127(13):16501655.

相似文献/References:

[1]雷贞武.各种先天性子宫异常与复发性流产的临床问题[J].中国计划生育和妇产科,2009,(06):0.
[2]万波,颜友良,胡文娟,等.心理干预与复发性流产妊娠结局的研讨[J].中国计划生育和妇产科,2013,(01):0.
　WAN Bo,YAN You-liang*,HU Wen-juan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[3]李树侠,张弘,陈昕,等.宫腔镜检查在复发性流产患者诊治中的作用[J].中国计划生育和妇产科,2013,(05):0.
　LI Shu-xia,ZHANG Hong,CHEN Xin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[4]庞小艳,邓小清,肖翠艳,等.复发性流产患者清宫术中个性化护理的临床观察[J].中国计划生育和妇产科,2014,(08):0.
　PANG Xiao-yan,DENG Xiao-qing,XIAO Cui-yan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(5):0.
[5]许雪如,魏冬梅,薛海琴,等.穴位按摩联合低分子肝素注射治疗妇科术后下肢深静脉血栓的效果[J].中国计划生育和妇产科,2015,(07):0.
　XU Xue-ru,WEI Dong-mei,XUE Hai-qin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(5):0.
[6]廖红玉.阿司匹林联合地塞米松孕前干预D2聚体升高型复发性流产的疗效分析[J].中国计划生育和妇产科,2015,(07):0.
　LIAO Hong-yu,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(5):0.
[7]李嘉蔚,刘国成,饶美兰*,等.复方丹参片联合低分子肝素治疗对早发型重度子痫前期围产结局的影响[J].中国计划生育和妇产科,2016,(12):36.
　LI Jia-wei,LIU Guo-cheng,RAO Mei-lan*,et al.Influence of compound salvia tablet and low molecular heparin on perinatal outcome of early onset severe preeclampsia[J].Chinese Journal of Family Planning & Gynecotokology,2016,(5):36.
[8]康丹阳,杨巧妮,乔宠*.应用血栓弹力图监测不同流产次数的复发性流产患者凝血功能变化情况[J].中国计划生育和妇产科,2017,(2):22.
　KANG Dan-yang,YANG Qiao-ni,QIAO Chong*.Application of thrombelastography to monitor the change of coagulation function in patients of recurrent spontaneous abortion in different times[J].Chinese Journal of Family Planning & Gynecotokology,2017,(5):22.
[9]刘素华*,赵阳阳,訾苹苹,等.肝素对复发性流产患者凝血功能、并发症及妊娠结局的影响[J].中国计划生育和妇产科,2017,(5):44.
　LIU Su-hua*,ZHAO Yang-yang,ZI Ping-ping,et al.Effect of heparin on coagulation function, complication and pregnancy outcome in patients with recurrent spontaneous abortion[J].Chinese Journal of Family Planning & Gynecotokology,2017,(5):44.
[10]杨纨,王海燕*.多囊卵巢综合征与复发性流产[J].中国计划生育和妇产科,2017,(10):1.
[11]欧玉华,张建平*.低分子肝素在复发性流产中应用的现状研究[J].中国计划生育和妇产科,2017,(10):10.

备注/Memo

备注/Memo:
广州市花都区科技计划项目（项目编号：17HDWS007）
更新日期/Last Update: 2020-05-25